Covx
San Diego
About Covx
Covx is a biotechnology company. It engages in the discovery and development of long-acting biological therapies called CovX-Bodies. Its products pipeline focuses on targets that inhibit tumor angiogenesis and modulate metabolic disorders. Their products pipeline includes CVX-045, a thrombospondin-1 mimetic CovX-Body; TSP-1, a negative regulator of angiogenesis that acts as a therapeutic target in oncology; CVX-060, a selective angiopoietin-2 antagonist COVX-BODY; and CVX-096, a long-acting GLP-1 mimetic COVX-BODY. Covx was founded by Carlos Barbas in 2002 and is headquartered in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Website: covx.com
- Phone: 858-964-2000
Canonical: https://fsome.com/organization/covx-3429093 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.